Our management board and team
Innovation in exchange with one another is a tradition we live by. That's why we work together in cross-functional and cross-site teams to find the best solutions.
Supervisory Board
Executive Committee
Benedikt von Braunmühl
- Chairman of the Supervisory Board of Pathoquest
- Chiron Vaccines (predecessor to Novartis Vaccines & Diagnostics)
- Vice President Latin America & Member of the Americas Management Council at Qiagen
- Senior VP, Head of Global Commercial Operations and Member of the Executive Committee at Qiagen
- Chief Operating Officer Diagnostic Services at Medicover
- CEO of HMNC Brain Health in Munich, Germany
- Since September 2023, CEO at Rentschler Biopharma SE
Christiane Bardroff
- Strong experience in the production of various biotechnology products, as well as in automation, IT and project management at Roche
- Senior Director Operations Biotech at Teva Biotech
- Since February 2022 SVP Client Program Management at Rentschler Biopharma
- Since May 2022 SVP Clinical and Commercial Manufacturing
- Since December 2022, Chief Operating Officer of Rentschler Biopharma SE
Gunnar Voss van Dahlen
- Over 17 years of experience as a CFO in internationally active, mid-sized private and public companies
- Expertise in finance, controlling, law, IT, and human resource management
- International management positions in the US, UK, Singapore, and Switzerland
- Since December 2023, Financial Officer at Rentschler Biopharma SE
Dr. Patrick Meyer
- PhD degree in molecular medicine and cellular biology
- Global Head BD Sales and Alliance Management at Rentschler Biopharma SE
- Since February 2025, Member of Executive Committee at Rentschler Biopharma SE
- Since February 2025, Global Head of Business Development at Rentschler Biopharma SE
Tom Roberts
- Leadership positions at Invictus Medical, 3M – KCI (formerly Acelity) and Roche Diagnostics
- Executive leadership, facilitated funding, and oversaw business and product development, regulatory compliance, manufacturing, and technology acquisition of a groundbreaking nanoparticle-based combination cancer therapeutic at Vitanova Biomedical
- Since September 2023, President Rentschler Biopharma Inc. and General Manager U.S., and member of the company’s Extended Executive Team
Andreas Löwe
- Biological technical assistant in cGMP production at Fresenius
- Vice President Controlling and Member Management Executive Committee at Fresenius SE
- Vice President Controlling, Procurement and Projects at Neovii Biotech
- Since 2020 Vice President Finance at Rentschler Biopharma
- Since June 2023 part of the Extended Management Team
As a reliable partner and passionate enabler in a volatile CDMO landscape, we are characterized by a solid foundation and a clear vision: Advancing medicine to save lives. Together. Every day, we are mastering the complex to achieve best solutions for our clients and their patients.
– Benedikt von Braunmühl, CEO Rentschler Biopharma
Business Development Team
Many hands, many minds – ONE TEAM
Our working environment is characterized by open, respectful cooperation, in which quality awareness, diligence and responsibility are paramount. And regardless of the diversity of our talents, we share one vision: Advancing medicine to save lives. Together.
Recruiting Team
Press Enquiries
